Back to search results

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Glioblastoma · Gliosarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California, Los Angeles (Data Collection Only), Los Angeles, California, United States

    Contact: Study coordinator (Phioanh Nghiemphu, MD) · 310-206-6909

  • University of Miami (Data collection only), Miami, Florida, United States

    Contact: Study coordinator (Macarena De La Fuente, MD)

  • Indiana University (Data Collection Only), Indianapolis, Indiana, United States

    Contact: Study coordinator (Kathryn Nevel, MD) · 317-948-5450

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Thomas Kaley, MD) · 212-639-5122

  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Thomas Kaley, MD) · 212-639-5122

  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Thomas Kaley, MD) · 212-639-5122

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Thomas Kaley, MD) · 212-639-5122

  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Thomas Kaley, MD) · 212-639-5122

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Thomas Kaley, MD) · 212-639-5122
    Contact: Study coordinator (Ingo Mellinghoff, MD) · 646-888-2766
    Contact: Principal Investigator (Thomas Kaley, MD)

  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States

    Contact: Study coordinator (Thomas Kaley, MD) · 212-639-5122

  • University of Vermont Medical Center, Burlington, Vermont, United States

    Contact: Study coordinator (Alissa Thomas, MD) · 802-847-8400
Study leads

  • Thomas Kaley, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)